Investment Summary

Altaris and Galen Partners Invest In JDS Pharmaceuticals

On October 19, 2005, private equity firm Altaris and growth capital firm Galen Partners invested in life science company JDS Pharmaceuticals

Investment Highlights
  • This is Altaris’ 1st and Galen Partners’ 2nd transaction in the Life Science sector.
  • This is Altaris’ 4th and Galen Partners’ 6th transaction in the United States.
  • This is Altaris’ 2nd and Galen Partners’ 2nd transaction in Pennsylvania.
Investment Fate
  • JDS Pharmaceuticals was sold to a publicly-traded strategic buyer in 2007 for 187M USD.

Investment Summary

Date 2005-10-19
Target JDS Pharmaceuticals
Sector Life Science
Investor(s) Altaris
Galen Partners
Deal Type Venture

Target

JDS Pharmaceuticals

Morrisville, Pennsylvania, United States
JDS Pharmaceuticals is a pharmaceutical company focused on the central nervous system. The company sold Pexeva and Lithobid® through its specialty sales force, and has a pipeline of products in clinical development. JDS Pharmaceuticals is based in Morrisville, Pennsylvania.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Altaris

New York City, New York, United States

Investor Investor Investor


Category Private Equity Firm
Founded 2003
PE ASSETS 10.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.


DEAL STATS #
Overall 4 of 39
Sector: Life Science M&A 1 of 9
Type: Venture M&A Deals 1 of 1
State: Pennsylvania M&A 2 of 5
Country: United States M&A 4 of 36
Year: 2005 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-08-15 Paragon Medical

Pierceton, Indiana, United States

Paragon Medical, Inc. is a provider of medical devices used in orthopedic surgical procedures. Paragon manufactures trays and cases for use in surgical delivery systems, surgical instruments, and precision manufactured implants for orthopedic medical device original equipment manufacturers. Paragon Medical was founded in 1991 and is based in Pierceton, Indiana.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-21 Oasis Outsourcing

West Palm Beach, Florida, United States

Oasis Outsourcing is a Florida-based Professional Employer Organization (PEO) serving almost 230,000 employees and 7,500 clients nationwide. Founded in 1996, it specializes in providing human resources services, employee benefits administration, payroll and tax administration, risk management services and staffing solutions to small- and medium-sized businesses throughout the United States. Oasis is accredited by the Employer Services Assurance Corporation (ESAC), ensuring the highest level of ethical, financial and operational standards in the PEO industry and has received SOC 1 Type II (formerly SAS 70) certification for its high level of accuracy and performance. Oasis, through its subsidiaries, is qualified to offer IRS-certified professional employer organization (CPEO) services.

Buy -
Investor

Galen Partners

Stamford, Connecticut, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1990
PE ASSETS 1.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.


DEAL STATS #
Overall 6 of 29
Sector: Life Science M&A 2 of 6
Type: Venture M&A Deals 3 of 13
State: Pennsylvania M&A 2 of 3
Country: United States M&A 6 of 28
Year: 2005 M&A 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-07-06 Dow Pharmaceutical Sciences

Petaluma, California, United States

Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-28 DAOU Systems

Exton, Pennsylvania, United States

DAOU Systems, Inc. is a provider of professional IT consulting and management services to healthcare organizations in the design, deployment, integration and support of infrastructure and application systems.

Sell -